questionText: To ask the Secretary of State for Science, Innovation and Technology, whether he plans to replace animal testing in the development of (a) monoclonal antibody therapies and (b) other drugs with more effective human-specific methods.
answerText: Regulatory approval processes already permit human-specific methods for drug testing where humans are the only relevant pharmacological species and the drug’s mechanism of action is well-defined and clinical monitoring is in place. This can include monocl...
heading: Animal Experiments